"
Team:Tsinghua/Experiment
From 2009.igem.org
(→Synthesis of the Therapeutic DNA) |
|||
| Line 1: | Line 1: | ||
= Project 1 = | = Project 1 = | ||
==Synthesis of the Therapeutic DNA== | ==Synthesis of the Therapeutic DNA== | ||
| + | In this part, we aims at constructing a molecular cloning vector with a cos site which enables it to be packaged into the gene therapy vector- in other words, to construct a cosmid. In order to detect the expression of the therapeutic DNA, we construct this cosmid based on the scanfold of Parts-J61031 encoding a RFP-expressing segment. | ||
| + | |||
| + | This cosmid mainly consists of the following segments: | ||
| + | 1) origin of replication: we insert O gene and P gene from bacteriophage lambda into J61031, which are resoonsible for the late phase replication and package of the wild type circular bacteriophage lambda genome | ||
| + | |||
| + | 2) cos site: necessary for the specific package of the Therapeutic DNA into the gene therapy vector. | ||
| + | |||
| + | 3) RFP-expressing segment: originally integrated into the plamid of J61031. | ||
| + | |||
==Synthesis of the Gene Therapy Production System== | ==Synthesis of the Gene Therapy Production System== | ||
==Synthesis of the Targeted Biobrick== | ==Synthesis of the Targeted Biobrick== | ||
Revision as of 15:42, 15 August 2009
Contents |
Project 1
Synthesis of the Therapeutic DNA
In this part, we aims at constructing a molecular cloning vector with a cos site which enables it to be packaged into the gene therapy vector- in other words, to construct a cosmid. In order to detect the expression of the therapeutic DNA, we construct this cosmid based on the scanfold of Parts-J61031 encoding a RFP-expressing segment.
This cosmid mainly consists of the following segments: 1) origin of replication: we insert O gene and P gene from bacteriophage lambda into J61031, which are resoonsible for the late phase replication and package of the wild type circular bacteriophage lambda genome
2) cos site: necessary for the specific package of the Therapeutic DNA into the gene therapy vector.
3) RFP-expressing segment: originally integrated into the plamid of J61031.
